Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963300 | Vaccine | 2015 | 9 Pages |
Abstract
Antibody responses to the IIV4-ID were non-inferior to IIV3-ID for the A and matched B strains and superior for the unmatched B strains. IIV4-ID was well tolerated without any safety concerns. IIV4-ID may help address an unmet need due to mismatched B strains in previous influenza vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Geoffrey J. Gorse, Ann R. Falsey, Ayca Ozol-Godfrey, Victoria Landolfi, Peter H. Tsang,